Stammdaten
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
Unternehmen & Branche
| Name | IR-Med, Inc. |
|---|---|
| Ticker | IRME |
| CIK | 0001839133 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 540.673 USD |
| Beta | 0,59 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-06-30 | 10-Q | -701,000 | -0.01 | 175,000 | -625,000 | |
| 2025-03-31 | 10-Q | -773,000 | -0.01 | 124,000 | -493,000 | |
| 2024-12-31 | 10-K | -1,899,000 | -0.03 | 251,000 | -294,000 | |
| 2024-09-30 | 10-Q | -598,000 | -0.01 | 533,000 | 2,000 | |
| 2024-06-30 | 10-Q | -366,000 | -0.01 | 887,000 | 363,000 | |
| 2024-03-31 | 10-Q | -657,000 | -0.01 | 579,000 | -86,000 | |
| 2023-12-31 | 10-K | -4,909,000 | -0.07 | 999,000 | 365,000 | |
| 2023-09-30 | 10-Q | -1,179,000 | -0.02 | 1,773,000 | 1,212,000 | |
| 2023-06-30 | 10-Q | -1,109,000 | -0.02 | 2,622,000 | 2,008,000 | |
| 2023-03-31 | 10-Q | -1,350,000 | -0.02 | 2,373,000 | 1,720,000 | |
| 2022-12-31 | 10-K | -4,734,000 | -0.07 | 3,294,000 | 2,592,000 | |
| 2022-09-30 | 10-Q | -856,000 | -0.01 | 4,123,000 | 3,578,000 | |
| 2022-06-30 | 10-Q | -939,000 | -0.01 | 4,493,000 | 3,885,000 | |
| 2022-03-31 | 10-Q | -849,000 | 2,411,000 | 1,575,000 | ||
| 2021-12-31 | 10-K | -3,716,000 | 2,943,000 | 2,371 | ||
| 2021-09-30 | 10-Q | -730,000 | 3,696,000 | 3,288,000 | ||
| 2021-06-30 | 10-Q | -1,522,000 | 3,879,000 | |||
| 2021-03-31 | 10-Q | -444,000 | 4,151,000 | |||
| 2020-12-31 | 10-K | -752,000 | 2,090,000 | 1,401,000 | ||
| 2020-09-30 | 10-Q | -89,000 | -348,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.